Karriereverlauf von Ehab Elkhouly
Ehemalige bekannte Positionen von Ehab Elkhouly
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CANCER GENETICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2018 | 01.06.2019 |
| RESPONSE GENETICS, INC | Geschäftsführer | - | - |
Ausbildung von Ehab Elkhouly
| KasrAlAiny School of Medicine | Undergraduate Degree |
| Paul Merage School of Business | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Ägypten | 2 |
| 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RESPONSE GENETICS, INC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Cancer Genetics, Inc.
 Cancer Genetics, Inc. Medical SpecialtiesHealth Technology Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus: NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ. | Health Technology |
- Börse
- Insiders
- Ehab Elkhouly
- Erfahrung
